Table 5.
Univariate analysis of factors affecting treatment efficacy
| Effective group (n=107) | Ineffective group (n=17) | t/χ2 | P | |
|---|---|---|---|---|
| Age (year) | 29.1±4.1 | 32.5±4.2 | 3.166 | 0.002 |
| Gestational weeks (weeks) | 29.58±2.40 | 29.88±2.23 | 0.483 | 0.630 |
| BMI (kg/m2) | 24.66±1.37 | 25.39±0.67 | 2.151 | 0.034 |
| Fetal heart rate | 146.15±9.30 | 145.00±6.62 | 0.490 | 0.625 |
| Uterine height (cm) | 21.61±4.70 | 23.17±3.89 | 1.298 | 0.197 |
| Times of pregnancies | 3.719 | 0.156 | ||
| 1 time | 58 (54.21) | 6 (35.29) | ||
| 2 times | 39 (36.45) | 7 (41.18) | ||
| 3 times | 10 (9.34) | 4 (23.53) | ||
| Times of delivery | 4.479 | 0.214 | ||
| 0 times | 63 (58.88) | 7 (41.18) | ||
| 1 time | 32 (29.91) | 5 (29.41) | ||
| 2 times | 8 (7.48) | 3 (17.65) | ||
| 3 times | 4 (3.74) | 2 (11.76) | ||
| Place of residence | 0.614 | 0.433 | ||
| Urban area | 79 (73.83) | 11 (64.71) | ||
| Rural area | 28 (26.17) | 6 (35.29) | ||
| Smoking history | 1.324 | 0.250 | ||
| Yes | 24 (22.43) | 6 (35.29) | ||
| No | 83 (77.57) | 11 (64.71) | ||
| SBP at admission (mmHg) | 164.37±5.27 | 168.71±5.64 | 3.125 | 0.002 |
| DBP at admission (mmHg) | 98.55±5.22 | 102.24±5.70 | 2.674 | 0.009 |
| Fasting blood glucose at admission (mmol/L) | 7.67±0.30 | 7.86±0.37 | 2.347 | 0.021 |
| TC at admission (mmol/L) | 6.49±0.49 | 6.87±0.40 | 3.037 | 0.003 |
| TG at admission (mmol/L) | 2.42±0.32 | 2.68±0.30 | 3.137 | 0.002 |
| LDL-C at admission (mmol/L) | 3.40±0.36 | 3.72±0.47 | 3.257 | 0.002 |
| HDL-C at admission (mmol/L) | 1.18±0.28 | 1.02±0.22 | 2.246 | 0.027 |
| Therapeutic regimen | 6.979 | 0.008 | ||
| Magnesium sulfate alone | 45 (42.06) | 13 (76.47) | ||
| Combined treatment | 62 (57.94) | 4 (23.53) |
BMI: body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; TG: Triglyceride; LDL-C: Low-density lipoprotein-cholesterol; HDL-C: High-density lipoprotein-cholesterol.